• Blood Pressure
    • Josep Redón
    • Josep Redón: Influence Statistics

      Josep Redón

      Josep Redón

      Show email address

      Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain;, javier.perez-hernandez@inserm.fr, (J.P.-H.);, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Josep Redón:Expert Impact

      Concepts for whichJosep Redónhas direct influence:Blood pressure,Essential hypertension,Cardiovascular risk,Hypertensive patients,Cardiovascular disease,European society,Atrial fibrillation,Antihypertensive treatment.

      Josep Redón:KOL impact

      Concepts related to the work of other authors for whichfor which Josep Redón has influence:Blood pressure,Cardiovascular disease,Hypertensive patients,Type 2 diabetes,Arterial stiffness,Metabolic syndrome,Resistant hypertension.

      KOL Resume for Josep Redón


      Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain;, (J.P.-H.);, (O.M.-A.);, (A.F.-C.);, (J.R.)

      Hypertension Unit, Hospital CIínico Universitario, University of Valencia, Av. de Blasco Ibáñez, 13, València, Spain

      Cardiovascular and Renal Research Group. INCLIVA, Valencia, SPAIN


      Department of Medicine, Cardio-Renal Prevention Research Group. INCLIVA Research Institute, University of Valencia, Menendez y Pelayo, 4, Valencia 46010, Spain.

      INCLIVA Biomedical Research Institute, 46010 Valencia, Spain


      Internal Medicine Hospital Clínico de Valencia, 46010 Valencia, Spain;, (S.V.);, (C.B.);, (A.R.)

      Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain;, (O.M.-A.);, (M.G.);, (E.S.);, (J.R.)

      CIBERObn, Carlos III Health Institute, Madrid, Spain

      Pediatric Department, Consorcio Hospital General.

      Hypertension Clinic, Hospital Clinico, INCLIVA, University of Valencia, Valencia.


      INCLIVA Health Research Institute, University of Valencia, Spain; Health Institute Carlos III, CIBEROBN, Madrid, Spain. Electronic address:

      Deparment of Internal Medicine, Hospital Universitario Clinic de Valencia, Valencia, Valencia, Spain

      CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Madrid.

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Josep Redón is among the top experts in the world.
      Concept World rank
      pwv groups #1
      highest levels hypertensives #1
      rs2301241 polymorphism txn #1
      uae levels mirnas #1
      treatment clinical inertia #1
      association rs2197076 #1
      presence essential hypertension #1
      glucose overload rabphilin3a #1
      systolic proteinurics #1
      p04 rhythm creatinine #1
      irae female follow #1
      attributable risk death #1
      uae differences #1
      impact weight excess #1
      addition histological features #1
      events irae #1
      rph drosophila heart #1
      271 diabetic subjects #1
      hls plasma metabolites #1
      allcause mortality g1 #1
      prevalence aplas #1
      estudio apache #1
      supporting hypertension #1
      hdlc concentration prevalence #1
      surrogate endpoints patients #1
      methodology global risk #1
      albuminuria mir26a #1
      share survey physicians #1
      obesity status pwv #1
      metabolomic profile subjects #1
      zn mda #1
      stroke age distribution #1
      association mpc2 #1
      factors lipid disorders #1
      genotypes c573t polymorphism #1
      autonomic communities #1
      excretion rate sodium #1
      signature hypertension #1
      treatment controlled patients #1
      skinfold thickness study #1
      insulin homa age #1
      cbp olm aml #1
      polymorphism insertion #1
      zn mpc3 #1
      hypertensive subjects relationship #1
      regular school day #1
      symptoms range #1
      higher diversity lncrnas #1
      rs4359 polymorphism genotype #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Josep Redón

      KOL-Index: 23482

      BACKGROUND: Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the life-course. Our aim was to estimate worldwide trends in mean body-mass index (BMI) and a comprehensive set of BMI categories that cover underweight to obesity in children and adolescents, and to compare trends with those of adults.

      METHODS: We pooled 2416 population-based studies with measurements of height and weight on 128·9 million participants ...

      Known for Worldwide Trends | Bmi Prevalence | Pooled Analysis | 1 2 | Boys Obesity
      KOL-Index: 23344

      BACKGROUND: Studies have challenged the appropriateness of accepted blood pressure targets. We hypothesised that different levels of low blood pressure are associated with benefit for some, but harm for other outcomes.

      METHODS: In this analysis, we assessed the previously reported outcome data from high-risk patients aged 55 years or older with a history of cardiovascular disease, 70% of whom had hypertension, from the ONTARGET and TRANSCEND trials investigating ramipril, telmisartan, ...

      Known for Cardiovascular Outcomes | Blood Pressure | Myocardial Infarction | Sbp Mm Hg | Transcend Trials
      KOL-Index: 18639

      BACKGROUND: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes.

      METHODS: We pooled data from population-based studies that had collected data on ...

      Known for Worldwide Trends | Adults Diabetes | Pooled Analysis | Population Growth | Women Countries
      KOL-Index: 17961

      BACKGROUND: Diabetes has been defined on the basis of different biomarkers, including fasting plasma glucose (FPG), 2-h plasma glucose in an oral glucose tolerance test (2hOGTT), and HbA1c. We assessed the effect of different diagnostic definitions on both the population prevalence of diabetes and the classification of previously undiagnosed individuals as having diabetes versus not having diabetes in a pooled analysis of data from population-based health examination surveys in different ...

      Known for Diabetes Prevalence | Pooled Analysis | Sensitivity Hba1c | Glucose Fpg | Tolerance Test
      KOL-Index: 17588

      Aims: Current guidelines of hypertensive management recommend upper limits for systolic (SBP) and diastolic blood pressure (DBP). J-curve associations of BP with risk exist for some outcomes suggesting that lower limits of DBP goals may also apply. We examined the association between mean attained DBP and cardiovascular (CV) outcomes in patients who achieved an on-treatment SBP in the range of 120 to <140 mmHg in the Ongoing Telmisartan Alone and in Combination with Ramipril Global ...

      Known for Cardiovascular Outcomes | Pulse Pressure | 140 Mmhg | Heart Failure | Patients Risk
      KOL-Index: 17099

      BACKGROUND: Raised blood pressure is an important risk factor for cardiovascular diseases and chronic kidney disease. We estimated worldwide trends in mean systolic and mean diastolic blood pressure, and the prevalence of, and number of people with, raised blood pressure, defined as systolic blood pressure of 140 mm Hg or higher or diastolic blood pressure of 90 mm Hg or higher.

      METHODS: For this analysis, we pooled national, subnational, or community population-based studies that had ...

      Known for Blood Pressure | Worldwide Trends | Pooled Analysis | South Asia | Subsaharan Africa
      KOL-Index: 15977

      OBJECTIVE: To reach a consensus on the prognostic significance of new techniques of automated blood pressure measurement.

      METHODS: A Task Force on the prognostic significance of ambulatory blood pressure monitoring wrote this review in preparation for the Eighth International Consensus Conference (28-31 October 2001, Sendai, Japan). This synopsis was amended to account for opinions aired at the conference and to reflect the common ground reached in the discussions.


      Known for Blood Pressure | Task Force | Ambulatory Monitoring | Whitecoat Hypertension | Qkd Interval
      KOL-Index: 13951

      AIMS: Studies have shown a non-linear relationship between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and outcomes, with increased risk observed at both low and high blood pressure (BP) levels. We hypothesized that the BP-risk association is different in individuals with and without diabetes at high cardiovascular risk.

      METHODS AND RESULTS: We identified patients with (N = 11 487) or without diabetes (N = 19 450), from 30 937 patients, from 133 centres in 44 ...

      Known for Cardiovascular Risk | Blood Pressure | Death Patients | Mmhg Increased | Sbp Dbp
      KOL-Index: 13704

      BACKGROUND: Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it.

      METHODS: We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial ...

      Known for Blood Pressure | Type 1 Diabetes | Progression Microalbuminuria | Albumin Excretion | Initial Evaluation
      KOL-Index: 12460

      BACKGROUND: Renin is a key protein of the renin-angiotensin system involved in the physiological control of blood pressure; the renin gene is therefore a candidate for essential hypertension in humans. We tested the association between polymorphisms and haplotypes of the renin gene and the risk of hypertension and blood pressure levels in two Spanish populations.

      METHODS: Two population-based studies from different regions of Spain were performed. Study A included 1502 individuals (748 ...

      Known for Blood Pressure | Hypertension Risk | Renin Gene | Postmenopausal Women | Spanish Populations
      KOL-Index: 12239

      The present prospective study assessed the impact of birth weight (BW) and postnatal weight gain on blood pressure and metabolic profile during the first 5 years of life. One hundred thirty-nine newborns (63 women) born at term after uncomplicated pregnancies and in the absence of perinatal illness were included. Subjects were divided according to size at birth in small, appropriate, and large for gestational age. After the initial evaluation on the second day of life, infants were ...

      Known for Birth Weight | 5 Years | Uric Acid | Blood Pressure | Preschool Cholesterol
      KOL-Index: 12143

      BACKGROUND: Hypertension guidelines advise aggressive blood pressure (BP) lowering in patients with diabetes or high cardiovascular risk, but supporting evidence is limited. We analysed the impact of BP on cardiovascular events in well treated high-risk patients enrolled in a large clinical trial (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).

      METHODS: Twenty-five thousand five hundred and eighty-eight patients with atherosclerotic disease or diabetes ...

      Known for Ongoing Telmisartan | Blood Pressure | Baseline Sbp | Vascular Risk | 130 Mmhg
      KOL-Index: 12058

      The objective of this study was to analyze the relationship of polymorphisms of the angiotensin II AT1 receptor gene with microalbuminuria in a group of young adults with essential hypertension. Essential hypertensives, less than 50 years old, never previously treated with antihypertensive drugs, and in absence of diabetes mellitus were included. Office blood pressure (BP), 24-h ambulatory BP monitoring, urinary albumin excretion (UAE) measurements, and DNA analysis were performed. ...

      Known for Essential Hypertension | Gene Polymorphism | Angiotensin Receptor | Presence Microalbuminuria | Antihypertensive Drugs
      KOL-Index: 11366

      Ambulatory blood pressure (BP) monitoring has become useful in the diagnosis and management of hypertensive individuals. In addition to 24-hour values, the circadian variation of BP adds prognostic significance in predicting cardiovascular outcome. However, the magnitude of circadian BP patterns in large studies has hardly been noticed. Our aims were to determine the prevalence of circadian BP patterns and to assess clinical conditions associated with the nondipping status in groups of ...

      Known for Hypertensive Patients | Circadian Blood | Prevalence Nondipping | Pressure Patterns | Cardiovascular Risk

      Key People For Blood Pressure

      Top KOLs in the world
      Giuseppe Mancia
      blood pressure heart rate metabolic syndrome
      Suzanne Oparil
      blood pressure resistant hypertension cardiovascular disease
      Gianfranco Gianfranco
      blood pressure heart failure european society
      Alberto Zanchetti
      blood pressure hypertensive patients essential hypertension
      Jackson T Wright
      blood pressure african americans kidney disease
      Jan Albert Staessen
      blood pressure systolic hypertension renal denervation

      Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain;, javier.perez-hernandez@inserm.fr, (J.P.-H.);, omartinez@incliva.es, (O.M.-A.);, afloreschova@gmail.com, (A.F.-C.);, josep.redon@uv.es, (J.R.

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.